Murphy Andrew J
Regeneron Pharmaceuticals Inc · EVP Research
Murphy Andrew J is listed in filings as EVP Research at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Dec 11, 2025, including sale activity. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Aug 15, 2024 to Dec 11, 2025. Reported amounts are shown as $383.9K to $206.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.